Literature DB >> 19185110

Fournier's gangrene: vacuum-assisted closure versus conventional dressings.

Ralf Czymek1, Andreas Schmidt, Christian Eckmann, Ralf Bouchard, Birgit Wulff, Tillmann Laubert, Stefan Limmer, Hans-Peter Bruch, Peter Kujath.   

Abstract

BACKGROUND: Fournier's gangrene is a fulminant and destructive inflammation of the scrotum, penis, and perineum. The objective of this study was to compare 2 different approaches to wound management after aggressive surgical debridement.
METHODS: Data from 35 patients with Fournier's gangrene were prospectively collected (1996-2007). Once the patients were stabilized following surgery, they were treated with either daily antiseptic (polyhexanide) dressings (group I, n = 16) or vacuum-assisted closure (VAC) therapy (group II, n = 19).
RESULTS: The mean age of the patients was 58.2 years in group I and 57.2 years in group II. In both groups, the most common predisposing conditions were diabetes mellitus, chronic alcoholism, and obesity. Escherichia coli, streptococcal species, Pseudomonas aeruginosa, and Staphylococcus aureus were the most frequently isolated organisms. Length of hospital stay was 27.8 days +/- 27.6 days (mortality: 37.5%) in group I and 96.8 days +/- 77.2 days (mortality: 5.3%) in group II. Enterostomies were performed in 43.8% of group I patients and in 89.5% of group II patients.
CONCLUSIONS: VAC was associated with significantly longer hospitalization and lower mortality. A partial explanation is that some patients with severe sepsis died within the first 3 days after admission and thus could not undergo vacuum therapy. Since our clinical experience has shown that vacuum dressings are particularly effective in the management of large wounds, we use VAC primarily for this indication despite the considerable material requirements involved.

Entities:  

Mesh:

Year:  2009        PMID: 19185110     DOI: 10.1016/j.amjsurg.2008.07.053

Source DB:  PubMed          Journal:  Am J Surg        ISSN: 0002-9610            Impact factor:   2.565


  22 in total

Review 1.  Evaluation and Management of Necrotizing Soft Tissue Infections.

Authors:  Stephanie L Bonne; Sameer S Kadri
Journal:  Infect Dis Clin North Am       Date:  2017-09       Impact factor: 5.982

2.  Recent advances in the treatment of necrotizing fasciitis.

Authors:  Marina S Morgan
Journal:  Curr Infect Dis Rep       Date:  2011-10       Impact factor: 3.725

Review 3.  Injury to the male external genitalia: a comprehensive review.

Authors:  James Furr; Daniel Culkin
Journal:  Int Urol Nephrol       Date:  2017-02-08       Impact factor: 2.370

4.  Experience in management of Fournier's gangrene: a report of 24 cases.

Authors:  Longwang Wang; Xiaomin Han; Mei Liu; Yan Ma; Bing Li; Feng Pan; Wencheng Li; Liang Wang; Xiong Yang; Zhaohui Chen; Fuqing Zeng
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2012-10-18

5.  Fournier's gangrene current approaches.

Authors:  Omer F Ozkan; Neset Koksal; Ediz Altinli; Atilla Celik; Mehmet A Uzun; Oztekin Cıkman; Alpaslan Akbas; Ersin Ergun; Hasan A Kiraz; Muammer Karaayvaz
Journal:  Int Wound J       Date:  2014-08-22       Impact factor: 3.315

6.  Fournier's Gangrene: A Summary of 10 Years of Clinical Experience.

Authors:  Abdullah Oguz; Metehan Gümüş; Ahmet Turkoglu; Zübeyir Bozdağ; Burak Veli Ülger; Elif Agaçayak; Abdullah Böyük
Journal:  Int Surg       Date:  2015-04-10

7.  [Management of soft tissue infections in the region of the extremities and the trunk].

Authors:  P Kujath; H Shekarriz
Journal:  Unfallchirurg       Date:  2011-03       Impact factor: 1.000

8.  Using negative pressure therapy for improving skin graft taking on genital area defects following Fournier gangrene.

Authors:  Erkan Orhan; Dilek Şenen
Journal:  Turk J Urol       Date:  2017-08-01

Review 9.  Contemporary diagnosis and management of Fournier's gangrene.

Authors:  Avinash Chennamsetty; Iyad Khourdaji; Frank Burks; Kim A Killinger
Journal:  Ther Adv Urol       Date:  2015-08

Review 10.  [Clinical symptoms and therapy of necrotizing skin and soft tissue infections].

Authors:  P Kujath; M Hoffmann; E Schlöricke; L Unger; R Bouchard
Journal:  Chirurg       Date:  2012-11       Impact factor: 0.955

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.